Pevion Biotech grants CSL option to license exclusive commercialization rights to PEV7 in Australia and New Zealand

Pevion Biotech AG

Switzerland / Private Biopharma

Licensor

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

CSL Ltd.

Australia / Mid-Cap Biopharma ($1-$50 billion)

$15,811.0m on 09/02/2011 [market cap]

Licensee

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced